Trial data showed Ocrevus treatment slowed disability progression in PPMS, including patients who were older and had more ...
Mapi Pharma’s GA Depot was associated with stable disability scores over time in people with both RMS and PPMS, data show.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results